2023-05-02T12:45:17-05:00 2022-12-31 410746749 CLIFTONLARSONALLEN LLP TWO INTERNATIONAL PLACE 22ND FLOOR BOSTON MA 02110 990 2022-01-01 131949477 NEW YORK BLOOD CENTER INC NEWY 2125703000 310 EAST 67TH STREET NEW YORK NY 10065 DAVID BENCH CFO 2125703100 2023-05-01 1 DAVID BENCH XXX-XX-XXXX 0 LAURA J KENNEY P00202198 6177170831 2023-04-24 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DR CHRISTOPHER HILLYER 310 EAST 67TH STREET NEW YORK NY 10065 550388428 0 X NYBLOODCENTER.ORG X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION.SPECIFICALLY, NYBC EXISTS:- TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS.- TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH- TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT- TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS 20 19 2715 750 0 0 12767729 16625619 376487315 522611703 1786143 9634031 961506 1501429 392002693 550372782 96018 78741 0 0 151877885 204959862 0 0 246153 235730610 343108481 387704513 548147084 4298180 2225698 819022618 766718159 221102670 215065306 597919948 551652853 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THEWORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION,SEE SCH. O AND PART III, 4A-C. 0 0 291771532 78741 343783063 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS,TESTING OF BLOOD SAMPLES AND THE DISTRIBUTION OF THESE PRODUCTS TOHOSPITALS IN THE REGIONS SERVED BY NYBCE DIVISIONS. 185964927 178828640 MEDICAL PROGRAMS: (1) HEMOPHILIA SERVICES CONSORTIUM,(2) CLINICAL/TRANSFUSION THERAPY SERVICES, (3) BONE MARROW PROGRAM, AND (4) NATIONAL CORD BLOOD PROGRAM (COLLECTION, PROCESSING, AND STORAGE OF CORD BLOOD UNITS AND DISTRIBUTION OF THESE UNITS FOR TREATMENT OR RESEARCH PURPOSES) 18294575 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES AWIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD ANDBLOOD RELATED DISEASES. 496031034 1 1 0 1 0 0 0 0 0 0 1 1 0 1 1 1 1 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 X 394 0 1 2715 1 1 0 0 0 0 0 0 0 0 0 0 1 0 X 20 19 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA FL IL MA MD MI MN NC NJ NY PA RI TN VA WI X DAVID BENCH 2125703440 310 EAST 67TH STREET NEW YORK NY 10065 CHRISTOPHER D HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 50.00 X X 1923494 0 105959 YVES DENIZE TRUSTEE 1.00 X 0 0 0 DAVID DRISCOLL TRUSTEE 1.00 X 0 0 0 PHILIP J FALIVENE TRUSTEE 1.00 X 0 0 0 JOHN FERRETTI TRUSTEE 1.00 X 0 0 0 ARIEL FISHMAN TRUSTEE 1.00 X 0 0 0 OWEN GARRICK TRUSTEE 1.00 X 0 0 0 PETER LOPEZ TRUSTEE 1.00 X 0 0 0 AARON R MARCU TRUSTEE 1.00 X 0 0 0 THERESA RAGOZINE TRUSTEE 1.00 X 0 0 0 CHARLES REPPUCCI TRUSTEE (UNTIL 12/22) 1.00 X 0 0 0 JOHN L ROSENTHAL TRUSTEE 1.00 X 0 0 0 JAIME SHAMONKI TRUSTEE 1.00 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 1.00 X 0 0 0 PAUL M TORGERSON TRUSTEE 1.00 X 0 0 0 STEPHEN D WURTZLER TRUSTEE 1.00 X 0 0 0 AVERY AUGUST TRUSTEE 1.00 X 0 0 0 JUNG CHOI TRUSTEE 1.00 X 0 0 0 MARC KRAMER TRUSTEE 1.00 X 0 0 0 MARK SCHMIDTLEIN TRUSTEE 1.00 X 0 0 0 BERNADETTE TISO DEPUTY GENERAL COUNSEL/ASST SECRETARY 50.00 X 280617 0 57282 BETSY JETT SVP, CHIEF QUAL & REGULATORY OFFICER 50.00 X 482402 0 41969 BRUCE SACHAIS VP, CHIEF MEDICAL OFFICER 50.00 X 413145 0 64659 DAVID BENCH CHIEF FINANCIAL OFFICER 50.00 X 66584 0 3471 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 50.00 X 816855 0 100349 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 50.00 X 494826 0 69291 JOSEPH MOHR EVP AND CHIEF BUSINESS OFFICER 50.00 X 652461 0 80157 ROBERT PURVIS UNTIL 622 CHIEF OF STAFF 50.00 X 312863 0 38483 SHAKIMA WELLS ASSOCIATE GENERAL COUNSEL, ASSISTANT SECRETARY 50.00 X 195019 0 36293 ALEXANDRA JIMENEZ VICE PRESIDENT, MEDICAL DIRECTOR 50.00 X 285130 0 34993 ANDREA CEFARELLI SR. VP, CORPORATE COMMUNICATIONS 50.00 X 333117 0 36624 BARRY GREENE VP, CHIEF ADMINISTRATION OFFICER MEDICAL & SCIENCE 50.00 X 291891 0 43859 DAVID GRAHAM VP-NYBC DIVISIONS 50.00 X 360695 0 59228 DEBRA KESSLER VP - MEDICAL PROGRAMS & SERVICES 50.00 X 280924 0 53895 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 50.00 X 386333 0 67162 ERIC SENALDI DEPUTY CHIEF MEDICAL OFFICER 50.00 X 309387 0 59474 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 50.00 X 422813 0 32090 JONATHAN BARBA VP INFORMATION TECHNOLOGY 50.00 X 282911 0 37712 JOON MOON UNTIL 222 EXECUTIVE DIRECTOR, CONTROLLER ENTERPRISE 50.00 X 380379 0 8958 MAHTAB KHAN VICE PRESIDENT OF FINANCE 50.00 X 313587 0 25430 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 50.00 X 299631 0 34521 PATRICIA KILLEEN VP - ENTERPRISE BLOOD OPERATIONS OPTIMIZATION 50.00 X 372470 0 53204 RICHARD YOUNGBLOOD SR. VICE PRESIDENT, CHIEF OF STAFF 50.00 X 336814 0 14124 JEANNIE MASCOLINO SR. EXECUTIVE DIRECTOR-BLOOD COLLECTIONS 50.00 X 348117 0 57778 KARINA YAZDANBAKHSH VP, DIRECTOR, RESEARCH DEVELOPMENT LFKRI 50.00 X 312870 0 30962 MEGHAN WOOD VICE PRESIDENT, VENTURES & BUSINESS DEVELOPMENT 50.00 X 321021 0 40538 MOHANDAS NARLA VP - LFRKI 50.00 X 366521 0 47715 NANCY VAN BUREN ASSOCIATE MEDICAL DIRECTOR 50.00 X 298771 0 43244 11941648 0 1379424 323 0 1 0 INCEPT CORPORATION 4150 BELDEN VILLAGE STREET CANTON OH 44718 BLOOD DONOR MARKETING 3277489 ATOS IT SOLUTIONS AND SERVICES 4851 REGENT BLVD IRVING TX 75063 IT SERVICES 2692880 CROSSROADS COURIER 2008 ALTOM CT SAINT LOUIS MO 63146 MESSENGER 2242001 MARKHAM AND STEIN UNLIMITED 2424 S DIXIE HIGHWAY 3RD FLOOR MIAMI FL 33133 MARKETING SERVICES 2229452 ALL SYSTEMS MESSENGER 2735 GRAND AVENUE BELLMORE NY 11710 MESSENGER 1793715 60 14350028 2275591 205517 16625619 BLOOD SERVICES 621500 343783063 343783063 MEDICAL PROGRAMS 621500 178828640 178828640 522611703 944434 944434 1789 1789 1179838 0 1179838 1179838 1179838 8600269 104974 0 15646 8600269 89328 8689597 8689597 PURCHASE REBATES 319802 319802 319802 550372782 522931505 0 10815658 2662 2662 76079 76079 10554529 1266543 9287986 146656590 132296139 14318589 41862 13056221 12260005 793065 3151 24657394 22920402 1725694 11298 10035128 8996822 1035449 2857 2739014 886390 1852624 276142 276142 255590 255590 2070391 2070391 16613870 13706637 2738771 168462 3224930 3219514 3768 1648 3996963 1618517 2376963 1483 10321692 2206723 8114969 20191975 20191975 1585073 1447968 137105 449212 449212 14895323 10950210 3945113 3971854 3273096 698758 SUPPLIES 213491581 213318701 168543 4337 R&M & EQUIPMENT 14962400 12945005 2017395 MGMT FEE-HEMOPHILIA CON 13338650 13338650 COURIER/DELIVERY SERVIC 8189320 8186448 2843 29 12534501 12473336 50139 11026 548147084 496031034 51869897 246153 67043932 16040402 638260 54882833 68618283 76874325 34983628 30505576 5122267 5482551 320147467 228239860 95480765 91907607 1110391 970929 397038436 348523006 998148 148986656 140532782 819022618 766718159 55213705 60538989 7027086 7275208 5187292 151586671 149339025 221102670 215065306 X 597287659 551309084 632289 343769 597919948 551652853 819022618 766718159 2225698 -48492793 0 X 0 1 X 1 1 1 X 13590606 13809977 24165905 12767729 16625619 80959836 346596532 437376620 528661629 376487315 522931505 2212053601 360187138 451186597 552827534 389255044 539557124 2293013437 104344 120000 44804 28000 43525 340673 0 104344 120000 44804 28000 43525 340673 2292672764 11907059 6483089 1550871 1413224 2126061 23480304 11907059 6483089 1550871 1413224 2126061 23480304 372094197 457669686 554378405 390668268 541683185 2316493741 0.98970 0.98570 0.01010 0.01410 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 255590 255590 547891494 548147084 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 511873 584773 664413 255590 2016649 250000 250000 250000 250000 1000000 1500000 17121175 17121175 126038945 77737029 48301916 112531237 91237509 21293728 64456110 59265322 5190788 91907607 INVESTMENT FUNDS 348523006 F 348523006 RIGHT OF USE ASSET 140235697 SECURITY DEPOSITS HELD BY LANDLORDS 297085 140532782 FMV OF INTEREST RATE SWAP 66616 OTHER CURRENT LIABILITIES 2000000 OTHER LONG TERM LIABILITIES 128677 CAPITAL LEASES - ROU LIABILITY 147084327 TENANT SECURITY DEPOSITS 59405 149339025 X 499929822 -48492793 123905 -48368888 548298710 2070391 3681 2074072 550372782 546750260 123905 553343 677248 546073012 2070391 3681 2074072 548147084 PART X, LINE 2: THE ORGANIZATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE A NONPROFIT CORPORATION, EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). AS A NONPROFIT CORPORATION, THE ORGANIZATION IS ALSO EXEMPT FROM STATE AND LOCAL INCOME TAXES. THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO THE ORGANIZATION'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER IRC SECTION 511. THERE WAS NO UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEAR ENDED DECEMBER 31, 2022 AND PERIOD ENDED DECEMBER 31, 2021, RESPECTIVELY. PART XI, LINE 4B - OTHER ADJUSTMENTS: RECLASSIFICATIONS BETWEEN NET REVENUES AND EXPENSES 3,681. PART XII, LINE 4B - OTHER ADJUSTMENTS: RECLASSIFICATIONS BETWEEN NET REVENUES AND EXPENSES 3,681. CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, INVESTMENTS 2320858 0 0 0 0 0 0 2320858 0 2320858 0 0 1 1 1 0 PART III ACCOUNTING METHOD: 1 COLLEGE SCHOLARSHIPS 246 76079 PART III COLLEGE SCHOLARSHIPS ARE AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X 1 1 0 0 0 0 0 1 0 CHRISTOPHER D HILLYER PRESIDENT & CHIEF EXECUTIVE OFFICER 1237344 0 600000 0 86150 0 80769 0 25190 0 2029453 0 48650 0 ELIZABETH MCQUAIL EVP - OPS & MANUFACTURING/COO 689841 0 69661 0 57353 0 71189 0 29160 0 917204 0 36853 0 JOSEPH MOHR EVP AND CHIEF BUSINESS OFFICER 576387 0 55574 0 20500 0 42261 0 37896 0 732618 0 0 0 JORDANA SCHWARTZ SVP - GENERAL COUNSEL/SECRETARY 442195 0 42563 0 10068 0 31617 0 37674 0 564117 0 10068 0 BETSY JETT SVP, CHIEF QUAL & REGULATORY OFFICER 432516 0 42070 0 7816 0 30095 0 11874 0 524371 0 7816 0 BRUCE SACHAIS VP, CHIEF MEDICAL OFFICER 367885 0 40010 0 5250 0 26832 0 37827 0 477804 0 0 0 JED GORLIN VP, MEDICAL & REGULATORY AFFAIRS 320075 0 25599 0 77139 0 13412 0 18678 0 454903 0 0 0 DONNA STRAUSS VP - ENTERPRISE LABORATORY SERVICES 340468 0 25365 0 20500 0 35484 0 31678 0 453495 0 0 0 PATRICIA KILLEEN VP - ENTERPRISE BLOOD OPERATIONS OPT 326605 0 25365 0 20500 0 24839 0 28365 0 425674 0 0 0 DAVID GRAHAM VP-NYBC DIVISIONS 315688 0 24507 0 20500 0 24021 0 35207 0 419923 0 0 0 MOHANDAS NARLA VP - LFRKI 366521 0 0 0 0 0 21350 0 26365 0 414236 0 0 0 JEANNIE MASCOLINO SR. EXECUTIVE DIRECTOR-BLOOD COLLECT 331950 0 16167 0 0 0 30500 0 27278 0 405895 0 0 0 JOON MOON UNTIL 222 EXECUTIVE DIRECTOR, CONTROLLER ENTER 42149 0 0 0 338230 0 4385 0 4573 0 389337 0 0 0 ANDREA CEFARELLI SR. VP, CORPORATE COMMUNICATIONS 304608 0 13659 0 14850 0 32166 0 4458 0 369741 0 0 0 ERIC SENALDI DEPUTY CHIEF MEDICAL OFFICER 296099 0 13288 0 0 0 30497 0 28977 0 368861 0 0 0 MEGHAN WOOD VICE PRESIDENT, VENTURES & BUSINESS 299112 0 21909 0 0 0 5331 0 35207 0 361559 0 0 0 ROBERT PURVIS UNTIL 622 CHIEF OF STAFF 240960 0 45835 0 26068 0 18171 0 20312 0 351346 0 5568 0 RICHARD YOUNGBLOOD SR. VICE PRESIDENT, CHIEF OF STAFF 286814 0 50000 0 0 0 0 0 14124 0 350938 0 0 0 KARINA YAZDANBAKHSH VP, DIRECTOR, RESEARCH DEVELOPMENT L 291495 0 21375 0 0 0 29125 0 1837 0 343832 0 0 0 NANCY VAN BUREN ASSOCIATE MEDICAL DIRECTOR 284476 0 14295 0 0 0 12258 0 30986 0 342015 0 0 0 MAHTAB KHAN VICE PRESIDENT OF FINANCE 290024 0 23563 0 0 0 6434 0 18996 0 339017 0 0 0 BERNADETTE TISO DEPUTY GENERAL COUNSEL/ASST SECRETAR 265567 0 15050 0 0 0 19386 0 37896 0 337899 0 0 0 BARRY GREENE VP, CHIEF ADMINISTRATION OFFICER MED 272199 0 19692 0 0 0 19377 0 24482 0 335750 0 0 0 DEBRA KESSLER VP - MEDICAL PROGRAMS & SERVICES 261255 0 19669 0 0 0 26800 0 27095 0 334819 0 0 0 MONIQUE BROWN GEORGE VP - HUMAN RESOURCES 279081 0 20550 0 0 0 19870 0 14651 0 334152 0 0 0 JONATHAN BARBA VP INFORMATION TECHNOLOGY 269910 0 13001 0 0 0 23729 0 13983 0 320623 0 0 0 ALEXANDRA JIMENEZ VICE PRESIDENT, MEDICAL DIRECTOR 271380 0 13750 0 0 0 19672 0 15321 0 320123 0 0 0 SHAKIMA WELLS ASSOCIATE GENERAL COUNSEL, ASSISTANT 185769 0 9250 0 0 0 13437 0 22856 0 231312 0 0 0 PART I, LINES 4A-B THE INDIVIDUAL LISTED BELOW RECEIVED A SEVERANCE PAYMENT IN 2022. - JOON MOON - $338,230 THE ORGANIZATION HAS A SECTION 457(F) PLAN FOR ITS CEO, CHRISTOPHER D. HILLYER, AND THE OTHER PARTICIPANTS LISTED BELOW. SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN BENEFITS WERE VESTED AND PAID TO PARTICIPANTS IN 2022 AS FOLLOWS: - CHRISTOPHER HILLYER - $48,650 - ELIZABETH MCQUAIL - $36,853 - JORDANA SCHWARTZ - $10,068 - BETSY JETT - $7,816 - ROBERT PURVIS - $5,568 NEW PLAN BENEFITS FOR THE PARTICIPANTS IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN WERE ACCRUED IN 2022 AS FOLLOWS: - CHRISTOPHER HILLYER - $59,419 - ELIZABETH MCQUAIL - $40,689 - JORDANA SCHWARTZ - $10,267 - BETSY JETT - $8,745 - JOSEPH MOHR - $20,911 - ANDREA CEFARELLI - $1,666 - BRUCE SACHAIS - $5,482 - DAVID GRAHAM - $2,671 - DONNA STRAUSS - $4,984 - PATRICIA KILLEEN - $3,489 NEW PLAN BENFITS ACCRUED IN 2022 ARE SUBJECT TO A SUBSTANTIAL RISK OF FORFEITURE. PLAN BENEFIT AMOUNTS THAT BECOME VESTED TO PARTICIPANTS ARE INCLUDED IN THE TOTALS REPORTED IN SCHEDULE J, PART II, COLUMN (B)(III). NEW ACCRUALS OF PLAN BENEFITS ARE INCLUDED IN THE TOTALS REPORTED IN SCHEDULE J, PART II, COLUMN (C). PART I, LINE 7 UPON THE ORGANIZATION ACHIEVING CERTAIN BUDGET THRESHOLDS, EXECUTIVES OTHER THAN THE CEO WERE ELIGIBLE FOR MERIT BONUSES OF UP TO 10% OF THEIR ANNUAL BASE SALARIES, DETERMINED BY THEIR ACHIEVING PERFORMANCE BENCHMARKS ESTABLISHED BY SENIOR MANAGEMENT AND APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD. THE CEO'S ANNUAL BONUS IS DISCRETIONARY DETERMINED BY THE BOARD AND BASED ON PERFORMANCE. X 5 153925 COST X PROMOTION ITEMS 118 42617 COST X EVENT TICKETS 6 8975 COST 0 1 0 990 SCHEDULE M PART I LINE 19 THE NUMBER OF NON-CASH CONTRIBUTIONS RECEIVED IS REPORTED IN COLUMN (B). FORM 990, PART I THE ORGANIZATION'S FORM 990 FOR THE PERIOD ENDED DECEMBER 31, 2021 REPORTED A 9 MONTH TAX YEAR DUE TO A CHANGE IN FISCAL YEAR, EFFECTIVE APRIL 1, 2021. FORM 990, PART V, LINE 3B NEW YORK BLOOD CENTER INC. WILL REQUEST AN EXTENSION OF TIME TO FILE 2022 FORM 990-T. FORM 990, PART VI, SECTION A, LINE 4 BYLAWS WERE UPDATED TO PROMOTE CERTAIN FLEXIBILITIES AND CONFORM WITH UPDATED PRACTICES, WHILE MAINTAINING CONSISTENCY WITH APPLICABLE STATE NOT-FOR-PROFIT LAW. FORM 990, PART VI, SECTION B, LINE 11B FOLLOWING COMPLETION OF THE FINANCIAL AUDIT, THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM WITH THE INFORMATION PROVIDED BY MANAGEMENT, AND REVIEWED AND APPROVED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C EACH YEAR, AND ON AN AS-NEEDED BASIS, THE ORGANIZATION REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS, AND IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE ORGANIZATION MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE ORGANIZATION USED ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE UPON REQUEST. FORM 990, PART VI, SECTION A, LINE 1A: THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE, COMPRISED OF A CHAIR, VICE CHAIR, AND AT LEAST THREE ADDITIONAL MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD.